Global Lisinopril Market, By Disease (Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Others), Dosage (Tablet, Liquid, Others), Dosage Strength (10 mg/12.5 mg, 20 mg/12.5 mg, 20 mg/25 mg, Others), Brand (Zestoretic, Prinivil, Zestril, Others), Population Type (Children, Adults), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Global Lisinopril market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR 4.30% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
However, rising demand of Lisinopril due to increasing prevalence of hypertension and other cardiovascular diseases drives the global Lisinopril market. Moreover rising demand for less expensive drugs to manage medical conditions associated with the cardiovascular system also boost up the market growth. Rising healthcare expenditure in developing countries creates an opportunities in the market. But, drug recall and side effects associated with the drug may hamper the global Lisinopril market.
Lisinopril is the anhydrous form of long-acting angiotensin-converting enzyme (ACE) inhibitor with the anti-hypertensive activity. Lisinopril is a peptide derivative which inhibits angiotensin-converting enzyme (ACE) and competitively binds to ACE, which ultimately bocks the conversion of angiotensin I to angiotensin II. The common side effects of Lisinopril are headache, dizziness, persistent cough, low blood pressure, chest pain and others.
In 2018, it is estimated that the prescription filled for Lisinopril in U.S. is 97,608,879. It is one of the top selling drug in U.S.
This Lisinopril market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Lisinopril Market Scope and Market Size
The Lisinopril market is segmented on the basis of disease, dosage, dosage strength, brand, population type, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disease, the Lisinopril market is segmented into hypertension, heart failure, heart attack, strokes, diabetic kidney disease and others.
- On the basis of dosage, the Lisinopril market is segmented into tablet, liquid and others.
- On the basis of dosage strength, the Lisinopril market is segmented into 10 mg/12.5 mg, 20 mg/12.5 mg, 20 mg/25 mg and others.
- On the basis of brand, the Lisinopril market is segmented into Zestoretic, Prinivil, Zestril and others.
- On the basis of population type, the Lisinopril market is segmented into children and adults.
- On the basis of end-users, the Lisinopril market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, Lisinopril market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Lisinopril Market Country Level Analysis
Lisinopril market is analysed and market size information is provided by country, disease, dosage, dosage strength, brand, population type, end-users and distribution channel as referenced above.
The countries covered in the Lisinopril market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation North America accounts the largest market share due to the increased prevalence of hypertension and cardiovascular diseases. Moreover, cardiovascular diseases are the major problem or health challenge in U.S. Europe accounts the second largest market share due to changing lifestyle among the population. Asia-Pacific is expected to account for the largest market share over coming years for the Lisinopril market due to increased geriatric population as well as growing healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Lisinopril market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Lisinopril Market Share Analysis
Lisinopril market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Lisinopril market.
The major players covered in the Lisinopril market are Lupin Pharmaceuticals, Inc., Astrazeneca, Merck & Co., Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Cipla Inc., Apotex Inc., Aurobindo Pharma Ltd., Vitaris Inc., Sandoz AG, Watson Laboratories Inc., Hikma Pharmaceutical PLC., Par Pharmaceutical Companies, Inc. Pfizer Inc., Bausch Health Companies, Inc. AbbVie Inc., Torrent Pharmaceuticals, Zydus Cadila, Wockhardt, Amneal Pharmaceutical Inc., other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Lisinopril Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.